Nicole Forster
Basilea Pharmaceutica (Switzerland)(CH)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Phagocytosis and Immune Regulation, Cancer Research and Treatments
Most-Cited Works
- → Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1(2014)107 cited
- → Physical Association of HDAC1 and HDAC2 with p63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell Carcinoma(2011)107 cited
- → Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation(2008)100 cited
- → Post-SELEX Chemical Optimization of a Trypanosome-Specific RNA Aptamer(2008)80 cited
- → A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma(2011)73 cited
- → The Integrin αvβ3-5 Ligand MFG-E8 Is a p63/p73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers(2010)72 cited
- → Mcl-1 and FBW7 Control a Dominant Survival Pathway Underlying HDAC and Bcl-2 Inhibitor Synergy in Squamous Cell Carcinoma(2012)65 cited
- → Effect of Sample Storage on the Assay of Lipoprotein(a) by Commercially Available Radial Immunodiffusion and Enzyme-Linked Immunosorbent Assay Kits(1992)49 cited
- → p300 Protein Acetyltransferase Activity Suppresses Systemic Lupus Erythematosus-Like Autoimmune Disease in Mice(2007)44 cited
- → OTX2 mutations cause autosomal dominant pattern dystrophy of the retinal pigment epithelium(2014)44 cited